| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Nov 13, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Nov 13, 2024 | Nov 13, 2024 |
| 8-K | Report | Data | 8-K | Oct 11, 2024 | Oct 11, 2024 |
| 8-K | Report | Data | 8-K | Sep 16, 2024 | Sep 14, 2024 |
| 8-K | Report | Data | 8-K | Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 13, 2024 | Jun 30, 2024 |
| SC 13G/A | Report | AMENDMENT NO. 2 TO SCHEDULE 13G | Jul 10, 2024 | |
| SC 13G/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13G | Jul 10, 2024 | |
| 8-K | Report | Data | 8-K | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | Report | Data | 8-K | May 14, 2024 | May 14, 2024 |
| 10-Q | Report | Data | 10-Q | May 14, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | Apr 24, 2024 | Apr 24, 2024 |
| SC 13G/A | Report | SC 13G/A | Apr 15, 2024 | |
| SC 13D/A | Report | SC 13D/A | Apr 11, 2024 | |
| 8-K | Report | Data | 8-K | Apr 9, 2024 | Apr 8, 2024 |
| 8-K | Report | Data | 8-K | Mar 28, 2024 | Mar 28, 2024 |
| 10-K | Report | Data | 10-K | Mar 28, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Mar 4, 2024 | Mar 4, 2024 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | ACRIVON THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 13, 2024 | ||
| 8-K | Report | Data | 8-K | Feb 8, 2024 | Feb 7, 2024 |
| 8-K | Report | Data | 8-K | Jan 8, 2024 | Jan 8, 2024 |
| 8-K | Report | Data | 8-K | Dec 8, 2023 | Dec 4, 2023 |
| 8-K | Report | Data | 8-K | Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Sep 5, 2023 | Sep 5, 2023 |
| 8-K | Report | Data | 8-K | Aug 11, 2023 | Aug 11, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Jun 22, 2023 | Jun 22, 2023 |
| 8-K | Report | Data | 8-K | Jun 5, 2023 | May 30, 2023 |
| 8-K | Report | Data | 8-K | May 9, 2023 | May 9, 2023 |
| 10-Q | Report | Data | 10-Q | May 9, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 1, 2023 | May 1, 2023 |
| 8-K | Report | Data | 8-K | May 1, 2023 | May 1, 2023 |
| 8-K | Report | Data | 8-K | Apr 25, 2023 | Apr 25, 2023 |
| SC 13D/A | Report | SC 13D/A | Mar 30, 2023 | |
| 10-K | Report | Data | 10-K | Mar 28, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 28, 2023 | Mar 28, 2023 |
| 8-K | Report | Data | 8-K | Mar 13, 2023 | Mar 13, 2023 |
| 8-K | Report | Data | 8-K | Mar 3, 2023 | Mar 3, 2023 |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | ACRIVON THERAPEUTICS, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| 10-Q | Report | Data | 10-Q | Dec 15, 2022 | Sep 30, 2022 |
| SC 13D | Report | SC 13D | Nov 28, 2022 | |
| SC 13G | Report | SCHEDULE 13G | Nov 28, 2022 | |
| SC 13G | Report | SC 13G | Nov 25, 2022 | |
| SC 13G | Report | SC 13G | Nov 21, 2022 | |
| SC 13G | Report | SC 13G | Nov 18, 2022 | |
| 8-K | Report | 8-K | Nov 17, 2022 | Nov 14, 2022 |